Cargando…

Review of patient-reported outcome measures in chronic hepatitis C

BACKGROUND: Chronic hepatitis C (CHC) and its treatment are associated with a variety of patient-reported symptoms and impacts. Some CHC symptoms and impacts may be difficult to evaluate through objective clinical testing, and more easily measured through patient self-report. This literature review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleinman, Leah, Mannix, Sally, Yuan, Yong, Kummer, Shannon, L’Italien, Gilbert, Revicki, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547737/ https://www.ncbi.nlm.nih.gov/pubmed/22871087 http://dx.doi.org/10.1186/1477-7525-10-92

Ejemplares similares

Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study
por: Sapra, Sandhya, et al.
Publicado: (2014)

Multicountry Burden of Chronic Hepatitis C Viral Infection among Those Aware of Their Diagnosis: A Patient Survey
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2014)

Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary
por: Mathias, Susan, et al.
Publicado: (2013)

A history of health-related quality of life outcomes in psychiatry
por: Revicki, Dennis A., et al.
Publicado: (2014)

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation
por: Budd, David, et al.
Publicado: (2011)

Characterizing the burden of premature ejaculation from a patient and partner perspective: a multi-country qualitative analysis
por: Revicki, Dennis, et al.
Publicado: (2008)

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
por: Harris, Linda, et al.
Publicado: (2021)

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)
por: Hanssens, Linda, et al.
Publicado: (2008)

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
por: Boscoe, Audra N., et al.
Publicado: (2019)

Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome
por: Ryan, Michael, et al.
Publicado: (2019)

Measuring interictal burden among people affected by migraine: a descriptive survey study
por: Hubig, Lena T., et al.
Publicado: (2022)

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
por: Johnston, Karissa, et al.
Publicado: (2022)

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
por: Johnston, Karissa M, et al.
Publicado: (2022)

Patient preferences for important attributes of bipolar depression treatments: a discrete choice experiment
por: Ng-Mak, Daisy, et al.
Publicado: (2017)

C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
por: Trudel, Marie, et al.
Publicado: (1997)

Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
por: Harris, Linda, et al.
Publicado: (2022)

Journal of Patient-Reported Outcomes: aims and scope
por: Revicki, Dennis, et al.
Publicado: (2017)

The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
por: Deighton, Alison M., et al.
Publicado: (2021)

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
por: Harris, Linda, et al.
Publicado: (2023)

Comparison of “Word” vs. “Picture” version of the Free and Cued Selective Reminding Test (FCSRT) in older adults
por: Zimmerman, Molly E., et al.
Publicado: (2015)

Willingness to Pay for Sensory Attributes of Intranasal Corticosteroids Among Patients With Allergic Rhinitis
por: Mahadevia, Parthiv, et al.
Publicado: (2006)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Clostridium difficile Infection–Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds
por: Talbot, George H., et al.
Publicado: (2019)

Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies
por: Lee, Mei-Hsuan, et al.
Publicado: (2014)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
por: Johnston, Karissa M., et al.
Publicado: (2021)

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
por: Huang, Chung-Feng, et al.
Publicado: (2017)

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
por: Powell, Lauren C., et al.
Publicado: (2022)

Reliability and Validity of the 6‐Minute Walk Test in Hypophosphatasia
por: Phillips, Dawn, et al.
Publicado: (2019)

A stated preference survey to explore patient preferences for novel preventive migraine treatments
por: Hubig, Lena T., et al.
Publicado: (2022)

Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items
por: Hays, Ron D., et al.
Publicado: (2009)

Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary
por: Kleinman, Leah, et al.
Publicado: (2014)

Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
por: Lo, Siu Hing, et al.
Publicado: (2022)

Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary
por: Lipton, Richard B., et al.
Publicado: (2021)

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
por: Mannix, Sally, et al.
Publicado: (2016)

Optimizing clinical and organizational practice in cancer survivor transitions between specialized oncology and primary care teams: a realist evaluation of multiple case studies
por: Tremblay, Dominique, et al.
Publicado: (2017)

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk
por: Lee, Mei-Hsuan, et al.
Publicado: (2015)

Evaluated outcomes in patients with Chronic Hepatitis C
por: Ashtari, Sara, et al.
Publicado: (2013)

A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements
por: Lin, Yu-Ju, et al.
Publicado: (2018)

Adolescent body weight and health-related quality of life rated by adolescents and parents: the issue of measurement bias
por: Gandhi, Pranav K., et al.
Publicado: (2015)

Content validity of the National Comprehensive Cancer Network – Functional Assessment of Cancer Therapy – Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients
por: Krohe, Meaghan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sh9oik74ehes2tmin66jrnohvm